CONCLUSIONS

Treatment for hypogonadal men who desire fertility

preservation continues to be a challenge for physi-

cians. Low dose HCG appears to protect and support

continued spermatogenesis when given in conjunc-

tion with injectable or topical TRT.

REFERENCES

1. Mulligan T, Frickl MF, Zuraw QC et al: Prevalence

of hypogonadism in males aged at least 45 years:

the HIM study. Int J Clin Practice 2006;

60:

762.

2. Corona G, Rastrelli G, Monami M et al: Hypogo-

nadism as a risk factor for cardiovascular mor-

tality in men: a meta-analytic study. Eur J Endo-

crinol 2011;

165:

687.

3. Corona G, Monami M, Rastrelli G et al: Testos-

terone and metabolic syndrome: a meta-analysis

study. J Sex Med 2011;

272.

4. Zarrouf FA, Artz S, Grifﬁth J et al: Testosterone

and depression: systematic review and meta-

analysis. J Psychiatr Pract 2009;

15:

289.

5. de Souza GL and J. Hallak: Anabolic steroids and

male infertility: a comprehensive review. BJU Int

2011;

108:

1860.

6. Coviello AD, Matsumoto AM, Bremner WJ et al:

Low-dose human chorionic gonadotropin maintains

intratesticular testosterone in normal men with

testosterone-induced gonadotropin suppression.

J Clin Endocrinol Metab 2005;

90:

2595.

7. Araujo AB, O’Donnell AB, Brambilia DJ et al:

Prevalence and incidence of androgen deﬁciency

in middle-aged and older men: estimates from

the Massachusetts Male Aging Study. J Clin

Endocrinol Metab 2004;

89:

5920.

8. Lethbridge-Çejku M, Schiller JS and Bernadel L:

Summary Health Statistics for U.S. Adults: Na-

tional Health Interview Survey, 2002. Vital and

Health Statistics. Series 10, No. 222. Data from

the National Health Survey. Hyattsville: Depart-

ment of Health and Human Services, Centers for

Disease Control and Prevention, National Center

for Health Statistics 2004.

9. Moskovic DJ, Katz DJ, Akhavan A et al: Clomi-

phene citrate is safe and effective for long-term

management of hypogonadism. BJU Int 2012;

110:

1524.

10. Burnett-Bowie SA, Roupenian KC, Dere ME et al:

Effects of aromatase inhibition in hypogonadal

older men: a randomized, double-blind, placebo-

controlled trial. Clin Endocrinol, Epub ahead of

print June 25, 2008.

11. Anderson RA and Wu FC: Comparison between

testosterone enanthate-induced azoospermia and

oligozoospermia in a male contraceptive study. II.

Pharmacokinetics and pharmacodynamics of once

weekly administration of testosterone enanthate.

J Clin Endocrinol Metab 1996;

81:

896.

12. Dohle GR, Smit M and Weber RF: Androgens and

male fertility. World J Urol 2003;

21:

341.

13. Turek PJ, Williams RH, Gilbaugh JH 3rd et al: The

reversibility of anabolic steroid-induced azoosper-

mia. J Urol 1995;

153:

1628.

14. Cooper TG, Noonan E, von Eckardstein S et al:

World Health Organization reference values for

human semen characteristics. Human Reprod Up-

date 2010;

16:

231.

HUMAN CHORIONIC GONADOTROPIN PRESERVES SPERMATOGENESIS

650